ImportRefusal LogoImportRefusal

Gulf Pharmaceutical Industries - Julphar

⚠️ Moderate Risk

FEI: 3004504829 • Ras Al Khaimah, Ras Al Khaimah • UNITED ARAB EMIRATES

FEI

FEI Number

3004504829

📍

Location

Ras Al Khaimah, Ras Al Khaimah

🇦🇪
🏢

Address

Airport Rd, , Ras Al Khaimah, Ras Al Khaimah, United Arab Emirates

Moderate Risk

FDA Import Risk Assessment

45.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

15
Total Refusals
4
Unique Violations
11/30/2021
Latest Refusal
12/12/2005
Earliest Refusal

Score Breakdown

Violation Severity
68.9×40%
Refusal Volume
44.6×30%
Recency
17.7×20%
Frequency
9.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

275×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3333×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

Refusal History

DateProductViolationsDivision
11/30/2021
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
27DRUG GMPS
Division of Southeast Imports (DSEI)
7/31/2019
66VAA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/4/2017
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
27DRUG GMPS
Division of Southeast Imports (DSEI)
3/20/2017
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
333LACKS FIRM
Division of Southeast Imports (DSEI)
3/17/2017
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
333LACKS FIRM
Division of Southeast Imports (DSEI)
3/17/2017
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
333LACKS FIRM
Division of Southeast Imports (DSEI)
5/3/2016
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
27DRUG GMPS
New Orleans District Office (NOL-DO)
5/3/2016
62FBJ99ANTI-INFECTIVE, TOPICAL N.E.C.
27DRUG GMPS
New Orleans District Office (NOL-DO)
4/26/2016
56YAJ99ANTIBIOTIC N.E.C.
27DRUG GMPS
New Orleans District Office (NOL-DO)
3/19/2015
61PDY11GLYBURIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Northern Border Imports (DNBI)
1/13/2015
60LAC05ASPIRIN (ANALGESIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/19/2012
65LPJ99PROTECTANT N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/11/2007
64BCA25HYDROCHLOROTHIAZIDE (DIURETIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/11/2007
62OCB22CARVEDILOL (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/12/2005
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Gulf Pharmaceutical Industries - Julphar's FDA import refusal history?

Gulf Pharmaceutical Industries - Julphar (FEI: 3004504829) has 15 FDA import refusal record(s) in our database, spanning from 12/12/2005 to 11/30/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Gulf Pharmaceutical Industries - Julphar's FEI number is 3004504829.

What types of violations has Gulf Pharmaceutical Industries - Julphar received?

Gulf Pharmaceutical Industries - Julphar has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Gulf Pharmaceutical Industries - Julphar come from?

All FDA import refusal data for Gulf Pharmaceutical Industries - Julphar is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.